JPWO2020257327A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020257327A5 JPWO2020257327A5 JP2021575508A JP2021575508A JPWO2020257327A5 JP WO2020257327 A5 JPWO2020257327 A5 JP WO2020257327A5 JP 2021575508 A JP2021575508 A JP 2021575508A JP 2021575508 A JP2021575508 A JP 2021575508A JP WO2020257327 A5 JPWO2020257327 A5 JP WO2020257327A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- composition
- constrained
- acid
- salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962863651P | 2019-06-19 | 2019-06-19 | |
| US201962863666P | 2019-06-19 | 2019-06-19 | |
| US62/863,666 | 2019-06-19 | ||
| US62/863,651 | 2019-06-19 | ||
| PCT/US2020/038205 WO2020257327A1 (en) | 2019-06-19 | 2020-06-17 | Constrained peptides |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022537383A JP2022537383A (ja) | 2022-08-25 |
| JPWO2020257327A5 true JPWO2020257327A5 (de) | 2023-06-27 |
Family
ID=74040887
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021575508A Pending JP2022537383A (ja) | 2019-06-19 | 2020-06-17 | 拘束ペプチド |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP3986914A4 (de) |
| JP (1) | JP2022537383A (de) |
| KR (1) | KR20220044719A (de) |
| CN (1) | CN114206916A (de) |
| AU (1) | AU2020298164A1 (de) |
| BR (1) | BR112021025487A2 (de) |
| CA (1) | CA3143676A1 (de) |
| MX (1) | MX2021015879A (de) |
| WO (1) | WO2020257327A1 (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023215269A1 (en) * | 2022-05-06 | 2023-11-09 | The Regents Of The University Of California | Lacripep promotes neuroregeneration and maintains epithelial progenitor cell identity |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4804539A (en) * | 1986-07-28 | 1989-02-14 | Liposome Technology, Inc. | Ophthalmic liposomes |
| WO2011138228A1 (en) * | 2010-05-04 | 2011-11-10 | Trb Chemedica Ag | Aqueous composition for ophthalmic or dermal use |
| US20190381136A1 (en) * | 2017-02-21 | 2019-12-19 | Tearsolutions, Inc. | Stable peptide compositions |
-
2020
- 2020-06-17 CA CA3143676A patent/CA3143676A1/en active Pending
- 2020-06-17 KR KR1020227001822A patent/KR20220044719A/ko unknown
- 2020-06-17 AU AU2020298164A patent/AU2020298164A1/en active Pending
- 2020-06-17 WO PCT/US2020/038205 patent/WO2020257327A1/en unknown
- 2020-06-17 JP JP2021575508A patent/JP2022537383A/ja active Pending
- 2020-06-17 BR BR112021025487A patent/BR112021025487A2/pt unknown
- 2020-06-17 EP EP20826413.5A patent/EP3986914A4/de active Pending
- 2020-06-17 MX MX2021015879A patent/MX2021015879A/es unknown
- 2020-06-17 CN CN202080056506.8A patent/CN114206916A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2013312689B2 (en) | Novel compound with effects of thrombolysis, free radical scavenging and thrombus-targeting as well as preparation method and use thereof | |
| Zhang et al. | Protein prenylation: molecular mechanisms and functional consequences | |
| EP0590006B1 (de) | Synthetische pulmonäre oberflächenaktive peptide | |
| JPH04501257A (ja) | 心房性ナトリウム利尿ペプチドクリアランス阻害剤 | |
| EP3904326A1 (de) | Verfahren zur herstellung von treprostinil und treprostinilderivat-prodrugs | |
| IL100811A (en) | Synthetic peptides for poisoning bacteria of facial toxins and for the prevention and treatment of "shock" | |
| PT95582B (pt) | Processo para a preparacao de compostos peptidicos antagonistas do receptor do fibrinogenio | |
| JP2003523348A (ja) | ポリペプトイド肺サーファクタント | |
| JPH10506608A (ja) | 白血球接着のインヒビター | |
| PT97992B (pt) | Processo de preparacao de analogos de um patrimonio peptoide com resistencia a protease, e processo para a sintese de uma mistura de polimeros com eles relacionados | |
| US7087729B1 (en) | Peptide conjugates for the stabilization of membrane proteins and interactions with biological membranes | |
| JP2008526868A (ja) | 表面活性剤処置療法 | |
| JP6633523B2 (ja) | Ｐｓｄ−９５の二量体阻害剤脂肪酸誘導体 | |
| KR910009930A (ko) | 인슐린 유도체, 이의 제조방법, 이의 용도 및 이를 함유하는 약제 | |
| JPWO2020257327A5 (de) | ||
| US6613734B2 (en) | Peptides-containing liposomal surfactants | |
| JPH0253798A (ja) | 脂質及びポリペプチドを含む合成肺表面活性物質の製造法 | |
| JP2008546689A (ja) | モチリン様ペプチドを含む、安定に緩衝化された薬学的組成物 | |
| WO2008094905A2 (en) | Encapsulated hdl mimetic peptides | |
| BRPI0806819A2 (pt) | métodos e pelìculas de polipeptìdeo | |
| PT87535B (pt) | Processo para a preparacao de novos derivados prptidicos de anf e de composicoes farmaceuticas que os contem | |
| BRPI0306644B1 (pt) | Método para produzir um peptídeo modificado | |
| US5358933A (en) | Synthetic peptides for detoxification of bacterial endotoxins and for the prevention and treatment of septic shock | |
| US20120302503A1 (en) | PEPTIDES FOR PREVENTING OR TREATING A DISEASE OR DISORDER ASSOCIATED WITH CBP OR p300 MISREGULATION, AND METHODS FOR USE AND IDENTIFICATION THEREOF | |
| RU2021138703A (ru) | Конформационно ограниченные пептиды |